|
 |
|
|||||||
|
|||||||||
Copyright ©ERS Journals Ltd 2001
Increased nitrotyrosine in exhaled breath condensate in cystic fibrosis
1 Dept of Thoracic Medicine and 2 Dept of Cystic Fibrosis, Imperial College School of Medicine at the National Heart and Lung Institute
CORRESPONDENCE: P.J. Barnes, Dept of Thoracic Medicine, Imperial College School of Medicine at the National Heart and Lung Institute, Dovehouse Street, London, SW3 6LY, UK. Fax: 44 2073515675
Keywords: cystic fibrosis, exhaled nitric oxide, nitrate, nitrite, nitrotyrosine, oxidative stress
Received: August 16, 2000
Accepted February 25, 2001
This study was supported by the Hungarian Respiratory Society, Foundation for Patients with Lung & Heart Diseases (Hungary) and the British Lung Foundation (NHLI, UK).
Exhaled nitric oxide (ENO), a marker of inflammation in airway diseases is decreased in cystic fibrosis (CF) patients, perhaps because nitric oxide (NO) is metabolized to oxidative end-products. A stable product, 3-nitrotyrosine, may indicate local formation of reactive nitrogen species.
Whether NO metabolites in exhaled breath condensate may be increased in CF patients was investigated. The fractional concentration of ENO (Feno), nitrotyrosine and oxides of nitrogen in exhaled breath condensate from 36 stable CF patients were compared to 14 normal subjects using an enzyme immunoassay and fluorescence assay.
Nitrotyrosine levels in breath condensate were increased significantly in stable CF patients, compared with normal subjects (25.3±1.5 versus 6.3±0.8 ng·mL–1, p<0.0001). There was an inverse correlation between the levels of nitrotyrosine and the severity of lung disease. Feno levels were significantly lower in CF patients than in normal subjects (4.4±0.3 versus 5.6±0.4 (parts per billion), p<0.05). No correlation was found between nitrotyrosine and Feno levels in CF. There was no significant difference in the levels of nitrite and nitrate between CF patients and normals.
The elevation in nitrotyrosine may reflect increased formation of reactive nitrogen species such as peroxynitrite or direct nitration by granulocyte peroxidases, indicating increased oxidative stress in airways of cystic fibrosis patients.
This article has been cited by other articles:
|
|
 |
|
  I. Rahman Review: Antioxidant therapeutic advances in COPD Therapeutic Advances in Respiratory Disease, December 1, 2008; 2(6): 351 - 374. [Abstract] [PDF]
|
|
|
|
 |
|
 Z. L. Borrill, K. Roy, and D. Singh Exhaled breath condensate biomarkers in COPD Eur. Respir. J., August 1, 2008; 32(2): 472 - 486. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Jozsef, T. Khreiss, D. El Kebir, and J. G. Filep Activation of TLR-9 Induces IL-8 Secretion through Peroxynitrite Signaling in Human Neutrophils J. Immunol., January 15, 2006; 176(2): 1195 - 1202. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Horvath, J. Hunt, P. J. Barnes, and On behalf of the ATS/ERS Task Force on Exhaled Bre Exhaled breath condensate: methodological recommendations and unresolved questions Eur. Respir. J., September 1, 2005; 26(3): 523 - 548. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. E. Carpagnano, P. J. Barnes, J. Francis, N. Wilson, A. Bush, and S. A. Kharitonov Breath Condensate pH in Children With Cystic Fibrosis and Asthma: A New Noninvasive Marker of Airway Inflammation? Chest, June 1, 2004; 125(6): 2005 - 2010. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. E. Silkoff, F. A. Romero, N. Gupta, R. G. Townley, and H. Milgrom Exhaled Nitric Oxide in Children With Asthma Receiving Xolair (Omalizumab), a Monoclonal Anti-Immunoglobulin E Antibody Pediatrics, April 1, 2004; 113(4): e308 - e312. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Csoma, A. Bush, N. M. Wilson, L. Donnelly, B. Balint, P. J. Barnes, and S. A. Kharitonov Nitric Oxide Metabolites Are Not Reduced in Exhaled Breath Condensate of Patients With Primary Ciliary Dyskinesia Chest, August 1, 2003; 124(2): 633 - 638. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. L. Kinnula and J. D. Crapo Superoxide Dismutases in the Lung and Human Lung Diseases Am. J. Respir. Crit. Care Med., June 15, 2003; 167(12): 1600 - 1619. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. E. Carpagnano, P. J. Barnes, D. M. Geddes, M. E. Hodson, and S. A. Kharitonov Increased Leukotriene B4 and Interleukin-6 in Exhaled Breath Condensate in Cystic Fibrosis Am. J. Respir. Crit. Care Med., April 15, 2003; 167(8): 1109 - 1112. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. P. Bowler and J. D. Crapo Oxidative Stress in Airways: Is There a Role for Extracellular Superoxide Dismutase? Am. J. Respir. Crit. Care Med., December 15, 2002; 166(12): S38 - 43. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |